We have located links that may give you full text access.
SARS-CoV-2 respiratory viral loads and association with clinical and biological features.
Journal of Medical Virology 2020 September 6
PURPOSE: To determine the distribution of SARS-CoV-2 respiratory viral loads (VL) during the acute phase of infection and their correlation with clinical presentation and inflammation-related biomarkers.
METHODS: Nasopharyngeal swabs from 453 adult SARS-CoV-2-infected patients from the Department of Infectious Diseases, Besançon, France, were collected at the time of admission or consultation for RT-PCR analysis. Clinical information and concentrations of biological parameters (CRP, fibrinogen, LDH, prealbumin) were noticed.
RESULTS: Mean respiratory VL homogeneously decreased from 7.2 log10 copies/ml (95%CI: 6.6 to 7.8) on the first day of symptoms until 4.6 log10 copies/ml (95%CI: 3.8 to 5.4) at day 10 (slope=-0.24; R²=0.95). VL were poorly correlated with COVID-19 symptoms and outcome, excepted for dyspnea and anosmia, which were significantly associated with lower VL (p<0.05). CRP, fibrinogen, and LDH concentrations significantly increased over the first 10 days (median CRP concentrations from 36.8 mg/L at days 0-1 to 99.5 mg/L at days 8-10, p<0.01), whereas prealbumin concentrations tended to decrease.
CONCLUSION: Since SARS-CoV-2 respiratory viral loads regularly decrease in the acute phase of infection, determining the level of VL may help predicting the onset of virus shedding in a specific patient. However, the role of SARS-CoV-2 VL as a biomarker of severity is limited. This article is protected by copyright. All rights reserved.
METHODS: Nasopharyngeal swabs from 453 adult SARS-CoV-2-infected patients from the Department of Infectious Diseases, Besançon, France, were collected at the time of admission or consultation for RT-PCR analysis. Clinical information and concentrations of biological parameters (CRP, fibrinogen, LDH, prealbumin) were noticed.
RESULTS: Mean respiratory VL homogeneously decreased from 7.2 log10 copies/ml (95%CI: 6.6 to 7.8) on the first day of symptoms until 4.6 log10 copies/ml (95%CI: 3.8 to 5.4) at day 10 (slope=-0.24; R²=0.95). VL were poorly correlated with COVID-19 symptoms and outcome, excepted for dyspnea and anosmia, which were significantly associated with lower VL (p<0.05). CRP, fibrinogen, and LDH concentrations significantly increased over the first 10 days (median CRP concentrations from 36.8 mg/L at days 0-1 to 99.5 mg/L at days 8-10, p<0.01), whereas prealbumin concentrations tended to decrease.
CONCLUSION: Since SARS-CoV-2 respiratory viral loads regularly decrease in the acute phase of infection, determining the level of VL may help predicting the onset of virus shedding in a specific patient. However, the role of SARS-CoV-2 VL as a biomarker of severity is limited. This article is protected by copyright. All rights reserved.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app